Developer of treatments for peritoneal cancer.
| Date | Round | Amount |
|---|---|---|
| Jun 2024 | Seed UPyTher, an Eindhoven peritoneal-cancer biotech spin-off, raised an undisclosed seed round from Essential Investments, BOM and TTT Medtech. | — |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.